ANK2 | Ankyrin 2, neuronal | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
BACE1 | Beta-site APP-cleaving enzyme 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CACNA2D1 | Calcium channel, voltage-dependent, alpha 2/delta subunit 1 | FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CACNA2D2 | Calcium channel, voltage-dependent, alpha 2/delta subunit 2 | FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
CACNA2D3 | Calcium channel, voltage-dependent, alpha 2/delta subunit 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CACNB2 | Calcium channel, voltage-dependent, beta 2 subunit | Disease related genes FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Mixed |
CACNB3 | Calcium channel, voltage-dependent, beta 3 subunit | FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Mixed |
CACNB4 | Calcium channel, voltage-dependent, beta 4 subunit | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
CACNG1 | Calcium channel, voltage-dependent, gamma subunit 1 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CACNG2 | Calcium channel, voltage-dependent, gamma subunit 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CACNG3 | Calcium channel, voltage-dependent, gamma subunit 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CACNG4 | Calcium channel, voltage-dependent, gamma subunit 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CACNG6 | Calcium channel, voltage-dependent, gamma subunit 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CACNG7 | Calcium channel, voltage-dependent, gamma subunit 7 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CACNG8 | Calcium channel, voltage-dependent, gamma subunit 8 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDND1 | Claudin domain containing 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
CNTN2 | Contactin 2 (axonal) | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
EMB | Embigin | Predicted membrane proteins Transporters
| | | | | Mixed |
EPB41 | Erythrocyte membrane protein band 4.1 | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Expressed in all |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
GSG1 | Germ cell associated 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
HAMP | Hepcidin antimicrobial peptide | Disease related genes Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
KCNMB1 | Potassium large conductance calcium-activated channel, subfamily M, beta member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KCNMB2 | Potassium large conductance calcium-activated channel, subfamily M, beta member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KCNMB3 | Potassium large conductance calcium-activated channel, subfamily M beta member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
LYNX1 | Ly6/neurotoxin 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
LYPD6B | LY6/PLAUR domain containing 6B | Predicted secreted proteins Transporters
| | | | | Group enriched |
MICU1 | Mitochondrial calcium uptake 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
MICU2 | Mitochondrial calcium uptake 2 | Predicted intracellular proteins Transporters
| | | | | Expressed in all |
NEDD4 | Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase | Predicted intracellular proteins Transporters
| | | | | Mixed |
NETO1 | Neuropilin (NRP) and tolloid (TLL)-like 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
NETO2 | Neuropilin (NRP) and tolloid (TLL)-like 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PRPH2 | Peripherin 2 (retinal degeneration, slow) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
RBP2 | Retinol binding protein 2, cellular | Predicted intracellular proteins Transporters
| | | | | Group enriched |
SCN2B | Sodium channel, voltage-gated, type II, beta subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SCN4B | Sodium channel, voltage-gated, type IV, beta subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC3A1 | Solute carrier family 3 (amino acid transporter heavy chain), member 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC3A2 | Solute carrier family 3 (amino acid transporter heavy chain), member 2 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC9A3R1 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Expressed in all |
SLC9A3R2 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 | Predicted intracellular proteins Transporters
| | | | | Mixed |
SMDT1 | Single-pass membrane protein with aspartate-rich tail 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
STOM | Stomatin | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
TMEM178A | Transmembrane protein 178A | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
TMEM30A | Transmembrane protein 30A | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
TMEM30B | Transmembrane protein 30B | Predicted membrane proteins Transporters
| | | | | Mixed |